JENNIFER TUCKER: Open Payments
NPI 1972042604 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 26 payments from 11 companies in 2025. Trend: 2023 $150 · 2024 $219 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $189 |
| ABIOMED | 1 | $117 |
| Alnylam Pharmaceuticals Inc. | 4 | $114 |
| Merck Sharp & Dohme LLC | 4 | $112 |
| PFIZER INC. | 3 | $63 |
| ENDOTRONIX, INC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: JARDIANCE, AMVUTTRA, VERQUVO, VYNDAQEL, CAPVAXIVE, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, Kerendia, Wegovy.
Industry payments across HI — which companies pay providers there.
